Company profile: Cellectricon
1.1 - Company Overview
Company description
- Provider of advanced cell-based screening services to accelerate drug discovery, exploiting the Cellaxessยฎ Elektra platform. Discovery Services are ideal for compound profiling in excitable primary cells and native tissue, helping researchers identify phenotypic effects.
Products and services
๐
Key contacts
๐
๐
Financial details
๐
1.2 - Competitors and similar companies to Cellectricon
Lino Biotech
HQ: Switzerland
Website
- Description: Provider of focal molographyโan entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samplesโeliminating signal disturbances due to temperature changes or non-specific binding.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Lino Biotech company profile โ
Numerate
HQ: United States
Website
- Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Numerate company profile โ
Harbour Antibodies
HQ: United States
Website
- Description: Provider of transgenic mouse technology for engineering mice to produce high affinity human antibodies. Established in 2006, leveraging technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands). The company has developed two types of human immunoglobulin gene transgenic mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Harbour Antibodies company profile โ
Prism Pharma
HQ: United States
Website
- Description: Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Prism Pharma company profile โ
Sarissa Biomedical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Sarissa Biomedical company profile โ
๐
2.M&A buyers
2.1 Potential strategic acquirers in the sector
๐
๐
๐
๐
View all strategic buyers with complete profiles
Start Free Trial โ
2.2 - Strategic buyer groups for Cellectricon
๐
Buyer group 1: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 2: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 3: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellectricon
2.2 - Growth funds investing in similar companies to Cellectricon
๐
View all growth equity funds with complete profiles
Start Free Trial โ
4 - Top valuation comps for Cellectricon
4.2 - Public trading comparable groups for Cellectricon
๐ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ